# A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis

> **NCT01369745** · PHASE2 · COMPLETED · sponsor: **Zalicus** · enrollment: 294 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Prednisolone
- **DRUG:** dipyridamole
- **DRUG:** Prednisone
- **DRUG:** Z102
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01369745
- **Lead sponsor:** Zalicus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2014-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01369745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01369745, "A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01369745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*